Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

Ensure Cardiac Resynchronization Therapy Study

ClinicalTrials.gov ID: NCT00291564

Public ClinicalTrials.gov record NCT00291564. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 6, 2026, 5:34 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to gather information on how doctors program particular settings on cardiac resynchronization therapy implantable cardiac defibrillators (CRT-Ds), to analyze how these settings affect the amount of cardiac resynchronization therapy (CRT) patients receive and to evaluate the therapy approach for converting abnormally fast heartbeats into normal heartbeats. There are no experimental devices or procedures involved in this study.

Study identification

NCT ID
NCT00291564
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Enrollment
430 participants

Conditions and interventions

Conditions

Interventions

Device

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2004
Primary completion
Not listed
Completion
Jan 31, 2006
Last update posted
Dec 20, 2007

2004 – 2006

United States locations

U.S. sites
32
U.S. states
27
U.S. cities
32
Facility City State ZIP Site status
Not listed Birmingham Alabama
Not listed Newport Beach California
Not listed Trumbull Connecticut
Not listed Daytona Beach Florida
Not listed Augusta Georgia
Not listed Kankakee Illinois
Not listed Indianapolis Indiana
Not listed Des Moines Iowa
Not listed Owensboro Kentucky
Not listed New Orleans Louisiana
Not listed Salisbury Maryland
Not listed Burlington Massachusetts
Not listed Detroit Michigan
Not listed Traverse City Michigan
Not listed Minneapolis Minnesota
Not listed Mexico Missouri
Not listed Omaha Nebraska
Not listed Bridgewater New Jersey
Not listed Englewood New Jersey
Not listed Charlotte North Carolina
Not listed Dayton Ohio
Not listed Lyndhurst Ohio
Not listed Oklahoma City Oklahoma
Not listed Portland Oregon
Not listed Abington Pennsylvania
Not listed Doylestown Pennsylvania
Not listed Columbia South Carolina
Not listed Nashville Tennessee
Not listed Houston Texas
Not listed Fairfax Virginia
Not listed Richmond Virginia
Not listed Seattle Washington

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00291564, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 20, 2007 · Synced Sep 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00291564 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →